Page last updated: 2024-08-26

sr141716 and Benign Neoplasms, Brain

sr141716 has been researched along with Benign Neoplasms, Brain in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bifulco, M; Catapano, G; Ciaglia, E; D'Alessandro, A; Fiore, D; Gazzerro, P; Laezza, C; Malfitano, AM; Pagano Zottola, AC; Picardi, P; Pisanti, S; Proto, MC; Torelli, G	1
Corbacho, C; de Ceballos, ML; Galve-Roperh, I; Gomez del Pulgar, T; Guzmán, M; Huffman, JW; Ramón y Cajal, S; Rueda, D; Sánchez, C; Velasco, G	1

Other Studies

2 other study(ies) available for sr141716 and Benign Neoplasms, Brain

Article	Year
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells. Oncotarget, 2015, Jun-20, Volume: 6, Issue:17 Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Brain Neoplasms; Cell Line, Tumor; G1 Phase Cell Cycle Checkpoints; Glioma; Histocompatibility Antigens Class I; Humans; Killer Cells, Natural; Mice; Mice, Nude; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays	2015
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer research, 2001, Aug-01, Volume: 61, Issue:15 Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Benzoxazines; Brain Neoplasms; Camphanes; Cannabinoids; Cell Division; Ceramides; Glioma; Growth Inhibitors; Humans; Mice; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001

Article

Year

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.

Oncotarget, 2015, Jun-20, Volume: 6, Issue:17

Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Brain Neoplasms; Cell Line, Tumor; G1 Phase Cell Cycle Checkpoints; Glioma; Histocompatibility Antigens Class I; Humans; Killer Cells, Natural; Mice; Mice, Nude; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays

2015

Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Cancer research, 2001, Aug-01, Volume: 61, Issue:15

Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Benzoxazines; Brain Neoplasms; Camphanes; Cannabinoids; Cell Division; Ceramides; Glioma; Growth Inhibitors; Humans; Mice; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001